Hidradenitis suppurativa-Pitfalls of long-term immunosuppressive treatment with tumor necrosis factor (TNF)-α inhibitors

Dermatol Ther. 2022 Aug;35(8):e15597. doi: 10.1111/dth.15597. Epub 2022 Jun 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / adverse effects
  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Immunologic Factors
  • Immunosuppressive Agents / adverse effects
  • Tumor Necrosis Factor-alpha

Substances

  • Immunologic Factors
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Adalimumab